Synthesis of various analog derivatives of ORG13514 as 5-HT(1A) ligands

Farmaco

Volumn 54, Issue 11-12, 1999, Pages 791-799

  Comoy, Corinne ^a   Benarab, Abdelhakim ^a   Leinot, Michel ^b   Monteil, André ^b   Guillaumet, Gérald ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b CERM Centre Europeen de Recherches Mauvernay   (France)

Author keywords

2,3 Dihydro 1,4 dioxino 2,3 b pyridine; 5 HT(1A) receptor binding; Anti depressant drug

Indexed keywords

3 AMINOMETHYL 2,3 DIHYDRO 1,4 DIOXINO[2,3 B]PYRIDINE; ANTIDEPRESSANT AGENT; ORG 13514; PYRIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DEPRESSION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; LIGAND BINDING; NONHUMAN; RAT; RECEPTOR AFFINITY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DIOXINS; ELECTROENCEPHALOGRAPHY; MALE; RADIOLIGAND ASSAY; RATS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGENTS; SLEEP; SPECTRUM ANALYSIS; SPIRO COMPOUNDS; WAKEFULNESS;

EID: 0033408487     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00106-8     Document Type: Article

References (39)

1. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Phamacol. Rev. 44:1992;401-458.
2. Humphrey P.P.A. 5-Hydroxytryptamine receptors and drug discovery. Langer S.Z., Brunello N., Racagni G., Mendlewicz J. Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications. 1:1992;129-139 Karger, Basel.
3. Teitler M. Cloning and functional expression of serotonin. Med. Chem. Res. 3:1993;273-286.
4. Herndon J.L., Glennon R.A. Serotonin receptors, agents and actions. Kozikowski A.P. Drug Design for Neuroscience. 1993;167-212 Raven, New York.
5. F. Saudou, R. Hen, 5-HT receptors subtypes: molecular and functional diversity, Med. Chem. Res. 5 (1994) 16-84.
6. Hoyer D., Martin G.R. Classification and nomenclature of 5-HT receptors, a comment on current issues. Behav. Brain Res. 73:1996;263-268.
7. Artigas F. 5-HT and antidepressants: new views from microdyalisis studies. Trends Pharmacol. Sci. 14:1993;262.
8. Blier P., Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
9. 1A receptor modulators. Bristol J.A. Annual Reports in Medicinal Chemistry. 30:1995;1-9 Academic Press, New York.
10. Barret J.E., Vanover K.E. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology. 112:1993;1-12.
11. Hamon M. Neuropharmacology of anxiety: perspective and prospects. Trends Pharmacol. Sci. 15:1994;36-39.
12. Richardson B.P., Hoyer D. Paoletti R. Serotonin: From Cell Biology to Pharmacology and Therapeutics. 1990;265-276 Kluwer, Dordrecht.
13. Taylor D.P., Moon S.L. Buspirone and related compounds as alternative anxiolytics. Neuropeptides. 19:1991;15-19.
14. Levy A.D., Van der Kar L.D. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics, and antidepressants. Life Sci. 51:1992;83-94.
15. 1A. J. Med. Chem. 31:1988;1087-1093.
16. 1A selective ligand and its effect in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepine. Br. J. Pharmacol. 99:1990;343-349.
17. 1A receptors: synthesis and characterization of 5-methoxy-3-[n-propyl-(4-n-aminobutyl]amino-3,4-dihydro-2H-1-benzopyran derivatives. Bioorg. Med. Chem. Lett. 3:1993;1935-1940.
18. 1A receptors, ligands and potential anxiolytic agents. I Synthesis and structure-activity relationships studies. J. Med. Chem. 37:1994;1779-1793.
19. Marot C., Comoy C., Viaud M.C., Rettori M.C., Pfeiffer B., Morin-Allory L., Guillaumet G. Synthesis, biological activity and quantitative structure-activity relationships of N-substitued-3,4-dihydro-2H-1-benzopyran derivatives. Bioorg. Med. Chem. 6:1996;1077-1082.
20. 1A receptors, ligands and potential anxiolytic agents. 2 Synthesis and quantitative structure-activity relationships studies of spiro[1-benzopyran-3(2H),2′-pyrrolidines and piperidines]. J. Med. Chem. 39:1996;4285-4298.
21. Benarab A., Guillaumet G. Synthesis and serotoninergic activity of 8-[4-(2,3-dihydro-1,4-dioxino[2,3-b]pyridin-2-yl-methylamino)butyl]-8- azaspiro[4,5]decane-7,9-dione. Heterocycles. 36:1993;2327-2333.
22. 1A ligands, Med. Chem. Res. 6 (1996) 392-399.
23. Benarab A., Comoy C., Guillaumet G. Synthesis of N-substituted imidoethyl-3-aminomethyl-2,3-dihydro-1,4-dioxino[2,3-b]pyridines. Heterocycles. 38:1994;1641-1650.
24. Benarab A., Poirot P., Guillaumet G. A new synthetic route to the previously unattainable 3-substitued-2,3-dihydro-1,4-dioxino[2,3-b] pyridines. Heterocycles. 36:1993;1589-1599.
25. Hu X.E., Cassady J.M. Selective O-benzylation of aminoalkanols. Synth. Commun. 25:1995;907-913.
26. Mitsunobu O., Wada M., Sano T. Stereospecific and stereoselective reactions. I Preparation of amines from alcohols. J. Am. Chem. Soc. 94:1972;679-680.
27. O. Mitsunobu, The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products, Synthesis (1981) 1-28.
28. 2 receptor binding sites; binding properties, brain distribution and functional role. Mol. Pharmacol. 21:1982;301-314.
29. 3H]-prazosin-labeled alpha 1-adrenergic receptors in rat brain and porcine neurointermediate lobe tissue. J. Neurochem. 41:1983;538-542.
30. Pazos A., Hoyer D., Palacios J.M. The binding serotonergic ligands to the porcine choroïd plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 106:1984;539-546.
31. 1B binding sites in bovine brain. Brain Res. 344:1985;167-171.
32. 1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;595-601.
33. 2-adrenergic receptors. Eur. J. Pharmacol. 76:1981;461-464.
34. 1A receptors induced lower lip retraction in the rat. Pharmacol. Biochem. Behav. 33:1989;821-827.
35. Anderson T.W. Introduction to Multivariate Statistical Analysis. 1958;Wiley, New York.
36. J.F.R. Konig, R.A. Klippel, The Rat Brain a Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem, Williams and Wilkins, Philadelphia, USA, 1963.
37. L.R. Morris, Fast Digital Signal Processing, Software Package, Digital Equipment User's Society (DECUS) Program Library, Reading, UK, 1976, pp. 11-296.
38. Ruigt G.S.F., Engelen S., Gerrits A., Verbon F. Computer-based prediction of psychotropic drug classed based on a discriminant analysis drug effects on rat sleep. Neuropsychobiology. 28:1993;138-153.
39. Perrin D.D., Armarego W.L.F., Perrin D.R. Purification of Laboratory Chemicals. 1986;Pergamon, Oxford.